Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Withdrawn 1Unknown 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Dermatologic 35Gastrointestinal 21Tumor-Agnostic 10Thoracic 10Gynecologic 8Other solid neoplasm 7Other hematologic neoplasm 7Breast 7Plasma cell 6CNS 6Sarcoma 5Lymphoid 4Head & Neck 4Genitourinary 4Myeloid 3Endocrine 3Classical hematology 1

Conditions

Sarcoma 2Xanthogranuloma, Juvenile 1Sarcoma, Clear Cell 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Histiocytosis, Sinus 1Histiocytosis, Langerhans-Cell 1Histiocytic Sarcoma 1Histiocytic Disorders, Malignant 1Fallopian Tube Neoplasms 1Erdheim-Chester Disease 1Endometrial Neoplasms 1Carcinosarcoma 1Breast Neoplasms 1

Interventions

Radiotherapy 220Doxorubicin 210Cyclophosphamide 210Temozolomide 182Ifosfamide 121Filgrastim 111Imatinib Mesylate 104Etoposide 101Vincristine 92Gemcitabine 89Bevacizumab 83Magnetic Resonance Spectroscopy 80Irinotecan 79pembrolizumab 75Radiation 69Carboplatin 65Methotrexate 62pazopanib 61Nivolumab 58Cisplatin 58fludarabine phosphate 57Peripheral Blood Stem Cell Transplantation 57Surgical Procedures, Operative 56Specimen Handling 56Trabectedin 52Docetaxel 50Biopsy 50Busulfan 49Melphalan 46Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
cobimetinib × Sarcoma × Clear all
NCT05691504 2026-05-13

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

National Cancer Institute (NCI)

Phase 1 Active not recruiting
42 enrolled
GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Endometrial Neoplasms

NCT04216953 2026-04-23

COTESARC

Centre Leon Berard

Phase 1/2 Completed
229 enrolled
Sarcoma

Sarcoma

NCT04079179 2025-09-18

NACHO-COBI

Baylor College of Medicine

Phase 2 Recruiting
90 enrolled
MyeloidSarcoma

Histiocytosis, Langerhans-Cell, Xanthogranuloma, Juvenile, Histiocytosis, Sinus, Histiocytic Disorders, Malignant, Erdheim-Chester Disease, Histiocytic Sarcoma

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

OHSU Knight Cancer Institute

Phase EARLY_PHASE1 Withdrawn
BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT02968303 2020-06-05

COWBOY

Radboud University Medical Center

Phase 2 Unknown
200 enrolled
Sarcoma

Sarcoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡